Search Results
10
Everything
EnteroBiotix Announces Positive Topline Phase 2a Results with EBX-102-02, a Potential First-in-Class Treatment for Irritable Bowel Syndrome (IBS)
March 18, 2025 04:00 ET
|
EnteroBiotix
EnteroBiotix Announces Positive Topline Phase 2a Results with EBX-102-02, a Potential First-in-Class Treatment for Irritable Bowel Syndrome (IBS) EBX-102-02 demonstrated clinically meaningful...
The Cabrach Trust challenges Canadian power giant over Scottish windfarm plan raised in Scottish Parliament
February 10, 2025 12:33 ET
|
The Cabrach Trust
Boralex's plans for a new wind farm in a remote Scottish Highland community have been raised in a Scottish Parliament debate.
Copenhagen Infrastructure Partners charges to the top of the UK battery stack
January 08, 2025 08:00 ET
|
Copenhagen Infrastructure Partners
LONDON, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Copenhagen Infrastructure Partners (CIP) has, through its flagship fund CI IV, taken Financial Investment Decision (FID) and issued Notice to Proceed (NTP)...
EnteroBiotix Completes Phase 2 Study Recruitment of EBX-102-02 in Irritable Bowel Syndrome
November 18, 2024 08:00 ET
|
EnteroBiotix
EnteroBiotix Completes Phase 2 Study Recruitment of EBX-102-02 in Irritable Bowel Syndrome 122 patients with moderate to severe irritable bowel syndrome (IBS) were recruited to EnteroBiotix’s Phase...
Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy
November 18, 2024 08:00 ET
|
Trogenix
Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy Company founded by 4BIO Capital and Professor Steve Pollard as a spinout from the...
EnteroBiotix Completes Phase 2 Study Recruitment of EBX-102-02 in Irritable Bowel Syndrome
November 18, 2024 03:00 ET
|
EnteroBiotix
EnteroBiotix Completes Phase 2 Study Recruitment of EBX-102-02 in Irritable Bowel Syndrome 122 patients with moderate to severe irritable bowel syndrome (IBS) were recruited to EnteroBiotix’s Phase...
Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy
November 18, 2024 02:00 ET
|
Trogenix
Trogenix Unveils Revolutionary Platform to Transform Cancer Treatment Through Precision Viral Immunotherapy Company founded by 4BIO Capital and Professor Steve Pollard as a spinout from the...
EnteroBiotix Announces Positive Ph1b Clinical Results of EBX-102 in Liver Cirrhosis
November 11, 2024 03:00 ET
|
EnteroBiotix
EBX-102 demonstrated proof-of-principle across multiple microbiome assessments, inflammatory biomarkers and clinical assessments, supporting its continued development as the first microbial therapy...
AEG Europe Secures Planning Permission for Edinburgh Park Arena
June 12, 2024 11:25 ET
|
AEG Europe
Edinburgh, UK, June 12, 2024 (GLOBE NEWSWIRE) -- AEG Europe, a global leader in live sport and entertainment, has received approved planning permission for a new state-of-the-art 8,500-capacity...
Boyden Expands Presence in Energy Sector with Acquisition of FWB's Energy Practice in Scotland
March 19, 2024 03:15 ET
|
Boyden
Boyden has acquired FWB's Energy Practice in Scotland, UK, further expanding the global organization's presence in the energy sector.